Search Results - "Bashyal, Krishna P"

Sex-based disparities and in-hospital outcomes of patients hospitalized with atrial fibrillation with and without dementia by Baral, Nischit, Mitchell, Joshua D., Aggarwal, Neelum T., Paul, Timir K., Seri, Amith, Arida, Abdul K., Sud, Parul, Kunadi, Arvind, Bashyal, Krishna P., Baral, Nisha, Adhikari, Govinda, Tracy, Melissa, Volgman, Annabelle Santos

“…We sought to evaluate the sex-based disparities and comparative in-hospital outcomes of principal AF hospitalizations in patients with and without dementia,…”
Get full text

COVID-19 Positive Status is Associated with Increased In-hospital Mortality in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis by Baral, Nischit, Abusnina, Waiel, Balmuri, Shravya, Seri, Amith, Kambalapalli, Soumya, Parajuli, Prem R, Abdelazeem, Basel, Bashyal, Krishna P, Ojha, Niranjan, Timilsina, Bidhya, Paul, Timir K

“…Patients hospitalized for acute myocardial infarction (AMI) may have concomitant positive coronavirus disease 2019 (COVID-19). We aimed to compare the risk of…”
Get full text

All-cause and in-hospital mortality after aspirin use in patients hospitalized with COVID-19: a systematic review and meta-analysis by Baral, Nischit, Mitchell, Joshua D, Savarapu, Pramod K, Akanbi, Maxwell, Acharya, Bandana, Kambalapalli, Soumya, Seri, Amith, Bashyal, Krishna P, Kunadi, Arvind, Ojha, Niranjan, Volgman, Annabelle Santos, Gupta, Tripti, Paul, Timir K

“…BackgroundWith the results of the largest randomized controlled trial (RECOVERY) and the most extensive retrospective cohort study on coronavirus disease 2019…”
Get full text

Abstract 12142: Cardiovascular Associations of Chimeric Antigen Receptor T-cell Therapy: A Retrospective Cohort Study From National Inpatient Sample 2016-2019 by Baral, Nischit, Santos Volgman, Annabelle S, Kunadi, Arvind, Abdelazeem, Basel, Saleh, Hassan, Kambalapalli, Soumya, Bashyal, Krishna P, Seri, Amith Reddy, Paul, Timir K, Ojha, Niranjan, parajuli, prem R, Mitchell, Joshua D

“…IntroductionAfter FDA approval in 2017, chimeric antigen receptor (CAR) T-cell therapy gained high popularity in various hematological malignancies…”
Get full text